Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2021 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Divergent adaptive immune responses define two types of long COVID.
Kervevan J, Staropoli I, Slama D, Jeger-Madiot R, Donnadieu F, Planas D, Pietri MP, Loghmari-Bouchneb W, Alaba Tanah M, Robinot R, Boufassa F, White M, Salmon-Ceron D, Chakrabarti LA. Kervevan J, et al. Front Immunol. 2023 Jul 20;14:1221961. doi: 10.3389/fimmu.2023.1221961. eCollection 2023. Front Immunol. 2023. PMID: 37559726 Free PMC article.
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.
Claireaux M, Robinot R, Kervevan J, Patgaonkar M, Staropoli I, Brelot A, Nouël A, Gellenoncourt S, Tang X, Héry M, Volant S, Perthame E, Avettand-Fenoël V, Buchrieser J, Cokelaer T, Bouchier C, Ma L, Boufassa F, Hendou S, Libri V, Hasan M, Zucman D, de Truchis P, Schwartz O, Lambotte O, Chakrabarti LA. Claireaux M, et al. Among authors: kervevan j. Nat Commun. 2022 Jan 26;13(1):521. doi: 10.1038/s41467-022-28130-0. Nat Commun. 2022. PMID: 35082297 Free PMC article.
Targeting human langerin promotes HIV-1 specific humoral immune responses.
Kervevan J, Bouteau A, Lanza JS, Hammoudi A, Zurawski S, Surenaud M, Dieudonné L, Bonnet M, Lefebvre C, Hocini H, Marlin R, Guguin A, Hersant B, Hermeziu O, Menu E, Lacabaratz C, Lelièvre JD, Zurawski G, Godot V, Henri S, Igyártó BZ, Levy Y, Cardinaud S. Kervevan J, et al. PLoS Pathog. 2021 Jul 29;17(7):e1009749. doi: 10.1371/journal.ppat.1009749. eCollection 2021 Jul. PLoS Pathog. 2021. PMID: 34324611 Free PMC article.
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
Gellenoncourt S, Saunders N, Robinot R, Auguste L, Rajah MM, Kervevan J, Jeger-Madiot R, Staropoli I, Planchais C, Mouquet H, Buchrieser J, Schwartz O, Chakrabarti LA. Gellenoncourt S, et al. Among authors: kervevan j. J Virol. 2022 Oct 12;96(19):e0130122. doi: 10.1128/jvi.01301-22. Epub 2022 Sep 19. J Virol. 2022. PMID: 36121299 Free PMC article.
Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells.
Cardinaud S, Urrutia A, Rouers A, Coulon PG, Kervevan J, Richetta C, Bet A, Maze EA, Larsen M, Iglesias MC, Appay V, Graff-Dubois S, Moris A. Cardinaud S, et al. Among authors: kervevan j. Eur J Immunol. 2017 May;47(5):818-829. doi: 10.1002/eji.201646603. Epub 2017 Apr 13. Eur J Immunol. 2017. PMID: 28266028 Free article.